Metabolik Sendrom İlişkili Parametrelerin Aşırı Aktif Mesane Üzerine Etkisi

Year 2020, Volume: 15 Issue: 3, 200 - 206, 27.10.2020

Arif Aydın , Mahmut Sami Tuzcu , Adeviye Elçi Atılgan , Mehmet Giray Sönmez , Serkan Özcan , Yunus Emre Göger Mehmet Balasar

https://doi.org/10.33719/yud.734639

Abstract

Amaç: Aşırı aktif mesane(AAM) ani sıkışma ile karakterize ve yaşam kalitesini olumsuz etkileyen bir durumdur. Yaş, obezite, parite, diabetes mellitus (DM), hiperlipidemi gibi durumların aşırı aktif mesane ile ilişkisi olduğu gösterilmiştir. Bu çalışmada aile hekimliği polkliniğine ürolojik semptomlar dışında başvuran hastaların boy,kilo, bel ve kalça çevresi, beden kütle endeksi gibi demografik verileri ile birlikte glukoz, kolesterol, hemoglobin gibi laboratuar verilerinin aşırı aktif mesane ile ilişkisi araştırılmıştır.

Gereç ve Yöntemler: Aile hekimliği polikliniğine başvuran 100 kadın hastanın yaş, boy, kg, beden kütle endeksi(BMI), bel/kalça oranı, bel/boy oranı gibi demografik verileri ile birlikte, kan glukoz, kolesterol, trigliserit (TG), Hemoglobin, TSH, Vit D3, Vit B12 gibi laboratuar değerlerinin bu hastalara doldurulan AAM semptom skoru (OAB-V8) anketinin sonuçları ile karşılaştırıldı ve etkisi değerlendirildi.

Bulgular: Hastaların OAB-V8 semptom skorunu; yaş, kg, BMI, Bel çevresi, Bel/kalça oranı, bel/boy oranı ve total kolesterol değerleri ile arasında korelasyon olduğu tespit edildi. Total kolesterol yüksekliği, birden çok kronik hastalık varlığı, hemoglobinin 12’den yüksek olması ve santral tip obezitenin aşırı aktif mesane semptom skoru anket puanını artırdığı saptandı.

Sonuç: Aşırı aktif mesane multifaktöriyel bir hastalık olup yaş, santral tip obezite ve birden fazla kronik hastalık varlığı AAM semptomları üzerinde etkili olabilir.

Keywords

AAM , Obezite , yaş , OAB-V8 , Hiperlipidemi

Effect of Metabolic Syndrome-Related Parameters on Overactive Bladder

Abstract

Objective: Over active bladder (OAB) is a situation characterized by urgency which negatively affects quality of life. Associations have been shown between situations like age, obesity, parity, DM and hyperlipidemia with OAB. In this study, patients attending a family practice clinic without urologic symptoms had demographic and laboratory data researched for correlation with OAB.

Material and Methods: A total of 100 female patients attending a family practice clinic had demographic features like age, height, weight, BMI, waist/hip ratio, and waist/height ratio and laboratory values like blood glucose, cholesterol, TG, hemoglobin, TSH, vitamin D3 and vitamin B12 compared for their effect on the OAB-V8 survey.

Results: The OAB-V8 symptom score of patients was identified to have correlations with age, weight, BMI, waist circumference, waist-hip ratio, waist-height ratio and total cholesterol levels. Elevated total cholesterol, presence of more than one chronic disease, hemoglobin above 12 and central-type obesity were identified to increase OAB-V8 symptom score.

Conclusion: OAB is a multifactorial disease and age, central-type obesity and more than one chronic disease may affect OAB symptoms.

Keywords

OAB , Obesity , Age , OAB-V8 , DM

References

• 1- Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P, et al. “Reviewing the ICS 2002 terminology report: the ongoing debate.” Neurourol Urodyn 2009; 28:287
• 2- Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. “An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.” Int Urogynecol J. 2010; 21: 5–26. doi: 10.1007/s00192-009-0976-9 PMID: 19937315
• 3- Coyne KS, Payne C, Bhattacharyya SK, et al. “The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey.” Value Health. 2004; 7:455-463.
• 4- Umek W, Gleiss A, Bodner-Adler B, Reichardt B, Rinner C, Heinze G. “The role of prescription drugs in female overactive bladder syndrome-A population-wide cohort study.” Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):189-198. doi: 10.1002/pds.4920. Epub 2019 Dec 5
• 5- Garnica SV, Minassian VA, Platte RO, Sartorius J. “Overactive bladder and hyperlipidemia: Is there an association?” Female Pelvic Med Reconstr Surg. 2011 Mar; 17(2): 76-9. doi: 10.1097/SPV.0b013e31820e9dde.
• 6- Yeniel AO, Ergenoglu AM, Meseri R, Ari A, Sancar C, Itil IM. “Systemic atherosclerosis and voiding symptom.” Eur J Obstet Gynecol Reprod Biol. 2017 Mar; 210:306-309. doi: 10.1016/j.ejogrb.2017.01.005. Epub 2017 Jan 9.
• 7- Sari Motlagh R, Hajebrahimi S, Sadeghi-Bazargani H, Joodi Tutunsaz J. “Reliability and Validation of the International Consultation on Incontinence Questionnaire in Over Active Bladder to Persian Language.” Low Urin Tract Symptoms. 2015 May;7(2):99-101. doi: 10.1111/luts.12059. Epub 2014 Apr 21.
• 8- Stewart EF, Van Rooyen JB, Cundiff GW, Abrams P, Herzoq AR, Corey R, et al. “Prevalence and burden of overactive bladder in the United States.” World J Urol 2003; 20:327e36.
• 9- Irwin DE, Milsom I, HunsKaar S, Reilly K, Kopp Z, Herschorn S, et al. “Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.” Eur Urol 2006;50: 1306e14.
• 10- Lee YS, Lee KS, Jung JH, Han DH, Oh SJ, Seo JT, et al. “Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study”. World J Urol 2011; 29:185e90.
• 11- Homma Y, Yamaguchi O, Hayashi K. “Neurogenic Bladder Society Committee. An epidemiological survey of overactive bladder symptoms in Japan.” BJU Int 2005; 96:1314e8
• 12- Lapitan MC, Chye PL. Asia-Pacific Continence Advisory Board. “The epidemiology of overactive bladder among females in Asia: a questionnaire survey.” Int Urogynecol J Pelvic Floor Dysfunc 2001; 12:226e31.
• 13- Yu HJ, Liu CY, Lee KL, Lee WC, Chen TH. “Overactive bladder syndrome among community-dwelling adults in Taiwan: prevalence correlates, perception, and treatment seeking”. Urol Int 2006; 77:327e33.
• 14- Khullar V, Chapple C, Gabriel Z, Dooley JA. “The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis. Urology 2006;68(2 Suppl):38-48.
• 15- Abrams P, Kelleher CJ, Kerr LA, Rogers RG. “Overactive bladder significantly affects quality of life.” Am J Manag Care 2000;6: S580e90.
• 16- Peterson AC, Sehgal A, Crump RT, Baverstock R, Sutherland JM, Carlson K. “Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory.” Neurourol Urodyn. 2018 Mar;37(3):1095-1100. Doi:10.1002/nau.23420. Epub 2017 Oct 4.
• 17- Palma T, Raimondi M, Souto S, Fozzatti C, Palma P, Riccetto C. “Correlation between age and overactive bladder symptoms in young women in Brazil”. Actas Urol Esp. 2013; 37: 156–161. doi: 10.1016/j. acuro.2012.07.009 PMID: 23411070
• 18- Liu RT, Chung MS, Lee WC, Chang SW, Huang ST, Yang KD, et al. Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology. 2011; 78: 1040–1045. doi: 10.1016/j.urology.2011.05.017 PMID: 21958505
• 19- Fitzgerald MP, Link CL, Litman HJ, Travison TG, McKinlay JB. Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol. 2007; 52: 407–415. PMID: 17382458
• 20- Wen JG, Li JS, Wang ZM, Huang CX, Shang XP, Su ZQ, Lu YT, Suo ZH, Wang Y, Qin GJ, Zhang WX, Heesakkers JP. “The prevalence and risk factors of OAB in middle-aged and old people in China.” Neurourol Urodyn. 2014 Apr; 3(4):387-91. doi: 10.1002/nau.22429. Epub 2013 Jun 13.
• 21- Palma T, Raimondi M, Souto S, Fozzatti C, Palma P, Riccetto C. “Correlation between body mass index and overactive bladder symptoms in pre- menopausal women.” Rev Assoc Med Bras (1992). 2014 Mar-Apr;60(2):111-7.
• 22- Esen Yeşil, Merve Özdemir, Gözde Arıtıcı Çolak, Emine Aksoydan “Evaluatıon Of The Relationshıp Between Waıst Heıght Ratıo And Other Anthropometrıc Measures In The Risk Of Chronic Diseases” Acu Sağlık Bil Derg 2019; 10(2):241-246, https://Doi.Org/10.31067/ 0.2018.78
• 23- Lai HH, Helmuth ME, Smith AR, Wiseman JB, Gillespie BW, Kirkali Z; Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). “Relationship Between Central Obesity, General Obesity, Overactive Bladder Syndrome and Urinary Incontinence Among Male and Female Patients Seeking Care for Their Lower Urinary Tract Symptoms.” Urology. 2019 Jan;123:34-43. doi: 10.1016/j.urology.2018.09.012. Epub 2018 Oct 28.
• 24- Lee RK, Chung D, Chughtai B, Te AE, Kaplan SA. “Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms.” BJU Int. 2012 Aug;110(4):540-5. doi: 10.1111/j.1464-410X.2011.10819.x. Epub 2012 Jan 13.
• 25- Son H, Choi WS, Paick JS, Park WH. “Detrusor Overactivity in Hyperchoelsterolemia Rats.” Low Urin Tract Symptoms. 2012 Mar;4 Suppl 1:16-20. doi: 10.1111/j.1757-5672. 2011.00124.x.